Clinical Trials Directory

Trials / Sponsors / Tyra Biosciences, Inc

Tyra Biosciences, Inc

Industry · 7 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Low Grade Upper Tract Urothelial Carcinoma
Phase 22025-12-22
RecruitingEfficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Inv
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations
Phase 22025-06-27
RecruitingSafety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tu
Metastatic Hepatocellular Carcinoma, Solid Tumors, Solid Tumor, Adult
Phase 12025-04-24
RecruitingA Study of TYRA-300 in Children With Achondroplasia: BEACH301
Achondroplasia
Phase 22025-03-04
RecruitingSafety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alteratio
Locally Advanced Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Solid Tumor
Phase 12023-11-22
Active Not RecruitingA Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Ad
Healthy
Phase 12023-10-16
Active Not RecruitingSafety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor
Phase 1 / Phase 22022-11-22